<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 18 Aug 2026 15:14:21 -0400--><rss version="2.0">
    <channel>
        <title>Dermata Therapeutics, Inc. (DRMA) SEC Filings</title>
        <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/rss</link>
        <description>Dermata Therapeutics, Inc. (DRMA) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/dermatarx/files/theme/images/logo-sm.png</url>
                <title>Dermata Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities]]></title>
                <description><![CDATA[2 Related Documents: 25-NSE, EX-99.25]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001354457-26-000799/0001354457-26-000799.pdf</link>
                <pubDate>Mon, 17 Aug 26 16:23:09 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001354457-26-000799/0001354457-26-000799.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[6 Related Documents: 8-K, EX-4.1, EX-4.2, EX-10.1, EX-10.2, EX-99.1]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-038647/0001493152-26-038647.pdf</link>
                <pubDate>Mon, 17 Aug 26 08:31:09 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-038647/0001493152-26-038647.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-037127/0001493152-26-037127.pdf</link>
                <pubDate>Tue, 11 Aug 26 16:15:56 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-037127/0001493152-26-037127.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-037124/0001493152-26-037124.pdf</link>
                <pubDate>Tue, 11 Aug 26 16:14:17 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-037124/0001493152-26-037124.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8-K]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-036109/0001493152-26-036109.pdf</link>
                <pubDate>Wed, 05 Aug 26 08:30:53 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-036109/0001493152-26-036109.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-028884/0001493152-26-028884.pdf</link>
                <pubDate>Tue, 16 Jun 26 16:16:03 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-028884/0001493152-26-028884.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]></title>
                <description><![CDATA[5 Related Documents: S-8, EX-5.1, EX-23.1, EX-99.1, EX-FILING FEES]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-027275/0001493152-26-027275.pdf</link>
                <pubDate>Thu, 04 Jun 26 16:17:30 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-027275/0001493152-26-027275.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[EFFECT - Notice of Effectiveness]]></title>
                <description><![CDATA[EFFECT]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/9999999995-26-001810/9999999995-26-001810.pdf</link>
                <pubDate>Mon, 01 Jun 26 06:06:35 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/9999999995-26-001810/9999999995-26-001810.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership]]></title>
                <description><![CDATA[SCHEDULE 13D]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026642/0001493152-26-026642.pdf</link>
                <pubDate>Mon, 01 Jun 26 16:35:11 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026642/0001493152-26-026642.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]></title>
                <description><![CDATA[424B3]]></description>
                <link>https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026446/0001493152-26-026446.pdf</link>
                <pubDate>Fri, 29 May 26 17:26:10 -0400</pubDate>
                <guid isPermalink="true">https://ir.dermatarx.com/sec-filings/all-sec-filings/content/0001493152-26-026446/0001493152-26-026446.pdf</guid>
                                                                            </item>
            </channel>
</rss>